Latent autoimmune diabetes of adults (LADA): The informative value of autoantibodies


Cite item

Full Text

Abstract

Aim. To investigate the prevalence of autoantibodies (autoAbs) associated with the development of type 1 diabetes mellitus (T1DM) in latent autoimmune diabetes of adults (LADA) in the Russian Federation. Subjects and methods. A total of 96 patients (46 women and 50 men) with LADA were examined. All the patients underwent an immunological examination including the determination of autoAbs, such as glutamic acid decarboxylase autoAbs (GADA), islet antigen-2 auto-Abs (IA-2A), islet cell cytoplasmic auto-Abs (ICA), zinc transporter 8 auto-Abs (ZnT8A), and insulin auto-Abs (IAA). Results. GADAs were found in 61.5% of the examinees. ICAs were detected in 24%, IA-2As were observed in 57.3%. AutoAbs were more frequently observed in combination than alone. IAAs were least commonly seen in 8.3% and only in combinations. ZnT8As were found in 52.1% of the examinees and they were present alone in 5.2%. Conclusion. The antibodies that are most frequently observed in LADA are GADAs, IA-2As and ZnT8As. It is insufficient to identify only GADAs, as the latter are found in only 61.5% of the patients. IA-2As and ZnT8As, which are present in 57.3% and 52.1% of the patients, respectively, should also be used in the diagnosis of LADA. ICAs are much less commonly seen and along with IAAs may be additional markers for LADA.

References

  1. Basile K, Guy V, Schwartz S, Grant S. Overlap of Genetic Susceptibility to type 1 diabetes, type 2 diabetes, and Latent Autoimmune Diabetes in Adults. Curr Diab Report. 2014;14:550. doi: 10.1007/s11892-014-0550-9
  2. Laugesen E, Ostergaard JA, Leslie RDG. Latent autoimmune diabetes of the adults: current knowledge and uncertainty. Diabet Med. 2015l;32(7):843-852. doi: 10.1111/dme.12700
  3. Дедов И.И., Шестакова М.В., Кураева Т.Л., Титович Е.В., Никонова Т.В. Нозологическая гетерогенность, молекулярная генетика и иммунология аутоиммунного сахарного диабета. Вестник РАМН. 2015;2:189-195.
  4. Tuomi T, Santoro N, Caprio S, Cai M et al. The many faces of diabetes: a disease with increasing heterogeneity. Lancet. 2014;383:1084-1094. doi: 10.1016/S0140-6736(13)62219-9
  5. Liao Y, Xiang Y, Zhou Z. Diagnostic criteria of latent autoimmune diabetes in adults (LADA): a review and reflection. Front Med. 2012;6(3):243-247. doi: 10.1007/s11684-012-0201-y
  6. Wenzlau JM, Juhl K, Yu L, Moua O et al. The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human 1 type diabetes. Proceedings of the National Academy of Sciences of the United States of America. 2007;104(43):17040-17045. doi: 10.1073/pnas.0705894104
  7. Delitala AP, Pes GM, Fanciulli G, Maioli M et al. Organ-specific antibodies in LADA patients for the prediction of insulin dependence. Endocrine Res. 2016;11:1-6. doi: 10.3109/07435800.2015.1136934
  8. Zhou Z, Xiang Y, Ji L, Jia W et al. Frequency, Immunogenetics, and Clinical Characteristics of Latent Autoimmune Diabetes in China (LADA China Study). Diabetes. 2013;62:543-550. doi: 10.2337/db12-0207
  9. Hawa MI, Kolb H, Schloot N, Beyan H et al. Adult-onset autoimmune diabetes in Europe is prevalent with a broad clinical phenotype: action LADA 7. Diabetes Care. 2013;36:908-913. doi: 10.2337/dc12-0931
  10. Xiang Y, Huang G, Shan Z, Pan L, Luo S et al. Glutamic acid decarboxylase autoantibodies are dominant but insufficient to identify most Chinese with adult-onset non-insulin requiring autoimmune diabetes: LADA China study 5. Acta Diabetologica. 2015;52:1121-1127. doi: 10.1007/s00592-015-0799-8
  11. Lampasona V, Petrone A, Tiberti C et al. Zinc transporter 8 antibodies complement GAD and IA-2 antibodies in the identification and characterization of adult-onset autoimmune diabetes: Non Insulin Requiring Autoimmune Diabetes (NIRAD) 4. Diabetes Care. 2010;33:104-108. doi: 10.2337/dc08-2305
  12. Trabucchi A, Faccinetti NI, Guerra LL, Puchulu FM et al. Detection and characterization of ZnT8 autoantibodies could help to screen latent autoimmune diabetes in adult-onset patients with type 2 phenotype. Autoimmunity. 2012;45(2):137-142. doi: 10.3109/08916934.2011.604658

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2016 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 

Address of the Editorial Office:

  • Novij Zykovskij proezd, 3, 40, Moscow, 125167

Correspondence address:

  • Alabyan Street, 13/1, Moscow, 127055, Russian Federation

Managing Editor:

  • Tel.: +7 (926) 905-41-26
  • E-mail: e.gorbacheva@ter-arkhiv.ru

 

 © 2018-2021 "Consilium Medicum" Publishing house


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies